About The Medical Condition MDL17,043
Find the definition of the medical term MDL17,043. MDL17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
MDL17,043
| MDL17,043 Medical Condition |
|---|
What's The Definition Of The Medical Condition MDL17,043?
1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Unknown Primary Neoplasm Metastasis ‐ Metastases in which the tissue of origin…
- Regional Hospital Plannings ‐ Areawide planning for hospitals or planning of a particular hospital…
- Nerve Lesion, Sciatic ‐ Disease or damage involving the SCIATIC NERVE, which divides…
- Estradiol Antagonists ‐ Compounds which inhibit or antagonize the biosynthesis or action…
- Osteogrycin B ‐ A specific streptogramin group B antibiotic produced by Streptomyces…
- Vascular Stretch Receptor ‐ Receptors in the vascular system, particularly the aorta and…
- HHV-8 ‐ A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE,…
- Rolling Tremors, Pill ‐ Cyclical movement of a body part that can represent either a…
- Thalamic Nuclei ‐ Several groups of nuclei in the thalamus that serve as the major…
- Immunoadsorbents ‐ An insoluble support for an antigen or antibody used to adsorb…